We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · March 30, 2017

Herpes Zoster Vaccine Is Protective for Only 5 Years in Patients With Autoimmune Diseases

The Journal of Rheumatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Rheumatology
Longterm Effectiveness of Herpes Zoster Vaccine Among Patients With Autoimmune and Inflammatory Diseases
J. Rheumatol. 2017 Mar 15;[EPub Ahead of Print], H Yun, F Xie, JW Baddley, K Winthrop, KG Saag, JR Curtis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading